Crypto
$6.07
+21.97% · delayed 15 min
Injective has no revenue, no balance sheet and no annual report, because there is no company behind it to produce one. The profitability, debt and accounting checks used elsewhere on this site read a business's own accounts, so there is nothing here for them to measure — its price is set entirely by what someone else will pay, with no earnings underneath it to compare that price against.
What still works: price history below, backtesting what an investment would have done, and comparing it against the wider market.
Filter by minute, hour, day or week
Loading price history…
Go deeper
There are no filings to trace back to, but the market still gets written about.
Coverage from the last 30 days
Zcash Sealed $1.7B – Here's Everything You Need to Know
Yahoo Finance ·
What Crypto Whales Are Buying and Selling as August 2026 and the Fed Decision Near
Yahoo Finance ·
JPMorgan, South Korea's KB Kookmin are moving payments onchain
Yahoo Finance ·
Top 3 Altcoins to Watch For Fourth Week of July 2026
Yahoo Finance ·
Injective’s Form TA-1 Explained: The Transfer Agent Filing Reshaping INJ’s Future
Yahoo Finance ·